News & events
Eurospital Spa participated in the congress held in Bologna on 20-22 June 2022, an important opportunity to present the product line for fecal calprotectin determination (ECL).
Eurospital Spa has always been a market leader in diagnostic solutions for the differential diagnosis of chronic inflammatory bowel disease (IBD) and irritable bowel syndrome (IBS).
Glad to have met you, we invite you to visit our website for more information on our product line ECL.
Follow us on LinkedIn